PHP9 Assessment of Diagnostic Need for Magnetic Resonance Imaging in Medicare Patients with Pacemaker Implants  by Eggleston, A. et al.
sary antibiotic use. Public health campaignsmayhave an important role in improv-
ing appropriate antibiotic prescribing.
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OBJECTIVES: To estimate the potential unmet need for Magnetic Resonance Imag-
ing (MRI) amongMedicare patients with pacemaker implants, via the prevalence of
diagnoses and conditions for which MRI is the preferred investigation method.
METHODS: The data analyzed comprised of fee-for-service portion of the 2008
Medicare patient population. Using this sample, two issues were examined: the
prevalence of the diseases forwhichMRI is the preferred imagingmodality, and the
uptake rates of all imaging modalities for MRI-indicated beneficiaries with pace-
maker implants compared with those having no implants. For each of those dis-
eases for which MRI is the preferred modality we also identified any trade-offs
between lower MRI rates and higher rates for other imaging modalities in pace-
maker-implanted compared with non-implanted patients. RESULTS: There was
almost no use of MRI in the pacemaker-implanted population, whereas 13% of
patients without any kind of implant received an MRI in 2008. Clinical practice
appears in line with the contraindication for MRI in pacemaker-implanted pa-
tients. Cancer of the CNS and suspected Stroke are conditions which require
timely, accurate imaging for good therapeutic decision making. A total of 73% and
41% of non-paced subjects received whole body MRI for these conditions respec-
tively, compared with 1% of paced subjects for each disease. Similar diagnostic
discrepancies were observed for Motion disorders, Dementia, Chronic orthopaedic
pain and spinal disorders. Pacemaker implanted patients also had high rates of
co-morbidities. CONCLUSIONS: There seems to be a large unmet clinical need for
pacemakers and other implanted cardiac devices which allow MRI to be used as a
diagnostic method. The very high rate of MRI use in non-implanted patients with
acute, progressive and often fatal conditions of stroke and cancer, and its absence
of use in the same patient groups with implants is a concern. The use of MRI
conditional cardiac devices would facilitate greater diagnostic method choice.
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OBJECTIVES: The margin between the price of a drug and its reimbursement price
(yakkasa) is determined by negotiation between wholesalers and medical institu-
tions in Japan. The Ministry of Health, Labour andWelfare (MHLW) claims that the
yakkasa reflects the market value of drugs. Factors, however, influencing the yak-
kasa have not been clarified. The aim of this study was to investigate the current
status and determinants of the yakkasa of generic drugs. METHODS: The reim-
bursement price of a drug,which is determined by theMHLW in Japan, decreases in
proportion to the yakkasa every two years. To calculate the yakkasa, we used the
drug price lists of 2006, 2008, and 2010. We identified generic drugs with a higher
percentage margin for each year, and averaged the yakkasa by drugs. We then
investigated longitudinal trends in the range of the yakkasa. Furthermore, we ex-
plored factors associatedwith the larger percentagemargin. RESULTS: The generic
drugs with a higher percentage margin were: doxazosin mesilate (30.7%), famoti-
dine (29.7%), and manidipine hydrochloride (29.6%) in 2006; ofloxacin (31.1%), ceti-
rizine hydrochloride (27.4%), and actarit (25.8%) in 2008; and ofloxacin (24.1%),
cetirizine hydrochloride (23.2%), and levofloxacin (22.5%) in 2010. The yakkasa was
correlatedwith the logarithmic capital of genericmanufacturers, i.e., generic drugs
developed by larger companies had smaller margin. The coefficient of variance for
the yakkasa decreased every two years with the revision of drug prices.
CONCLUSIONS: The generic drugs prescribed frequently or developed recentlyhad
a higher percentage margin. The relationship between the yakkasa and capital
might signify the fact that more competitive manufacturers tend to paysmaller
margin, since medical institutions have no incentive to buy drugs from smaller
manufactures, unless the margin is larger.
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OBJECTIVES: China’s national pharmaceutical system has multiple Objectives: to
develop the domestic pharmaceutical industry and encourage innovation, to con-
trol total pharmaceutical expenditure (TPE) which represents the largest compo-
nent of total health expenditure (THE) in China, and to ensure equities for poor and
uninsured patients. The challenges to the current system with distorted market
incentives resulted in unaffordable drug costs and questionable prescribing prac-
tices that undermine public health. This study intended to examine the time trends
and determinants of total pharmaceutical expenditure in China.METHODS: Total
pharmaceutical expenditures over 1990-2009 were explained by amount of pre-
scriptions dispensed, proxy of health utilization, and price index over years includ-
ingmedical CPI. Data from China National Health Accounts Report was used. Time
trends of TPE as share of THE (TPE/THE) and of GDP (TPE/GDP), and the relationship
between TPE and GDP were examined descriptively. The growth of TPE was exam-
ined after adjusting for health utilization. Determinants of TPE/THE and TPE/GDP
were investigated by time-series regression models. RESULTS: Descriptive analy-
ses showed TPE/THE and TPE/GDP grew over the years 1990-2009. THE/GDP grew
faster in the recent few years than TPE/GDP. TPE per visit still rose over years after
adjusting for health utilization (inpatient and outpatient services). However,
health utilization was not shown the growth pattern along with the GDP growth
over 1990s. Time-series analyses showed TPE/THE was negatively influenced by
GDP (p  0.039) and medical CPI (p0.021). TPE/GDP was positively influenced by
price index of prescriptions (p0.000) and amount of health service use including
inpatient (p 0.012) and outpatient visits (p0.003). CONCLUSIONS: Both TPE and
THE increased over timewith the pace of GDP growth. The study provided evidence
of increasing economic burden on patients imposed by TPE in China. Rapid growth
in the China economy, however, may ameliorate the overall TPE burden.
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OBJECTIVES: To evaluate the quality and improve the quality control of vaccine
refrigerators at primary care units; PCU. METHODS: It was a quasi-experimental
study; pre-post intervention descriptive designwas studied. Computerized Transit
temperature data loggers were used to monitor vaccine refrigerator temperatures
at 19 PCU under the authority of Songkhla hospital. Data loggers, monitoring tem-
peratures from 40 0C to 850C, were programmed to record every 30 minutes for
15 days. Percentage of frequency which temperatures were out of 2-8 0C range and
maximum/minimum temperatures had been used for this evaluation. Results of
the study were sent back to PCU for adjustment.Post adjustment data were col-
lected for assessment RESULTS: Vaccine Refrigerators at PCU were household
models.Refrigerator ages average is 7.37 years. Before intervention, average per-
centage of frequency, which temperatureswere2 0 C and 8 0 C, was 13 .76% and
2.03% (range 0%-81% and 0%-11.23% respectively).19 units recorded temperatures
below 2 0 C and above 8 0 C at one point. The lowest and highest temperatures
recorded were 26.20 0 C and -70C. After assessment, 8 units required modifications
and 11 units got new refrigerators. Refrigerators age average was 2.68 years. Aver-
age percentage of frequency, temperatures2 0 C and 8 0 C, was 3.31% and 0.88%
(range 0%-51.48% and 0.88%-5.34% respectively). 6 units had no out of range tem-
peratures. The lowest and highest temperatures were -2.5 0 C and 190C. The per-
centage of frequency was decreased in 18 units but not statistically significant.
However, the lowest and highest temperatures was statistically significant de-
creased (p-value  0.004, 0.013 respectively) CONCLUSIONS: Using data logger
feedback can help maintain vaccine cold chain standard (2-8 0C). A data logger
should be used continually to monitor temperature in a vaccine refrigerator.
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OBJECTIVES: Affordability is one of the main objectives of national drug policies
but there are no clear indicators to determine whether a medicine is affordable.
The share ofmedication in consumer basket, comparing to GrossDomestic Product
(GDP) per capita and comparing to the daily income of the lowest paidworker in the
government have been some methods to judge about the affordability. This study
tries to investigate affordability of antibacterial therapy in Iran during last decade
(2001-2010). METHODS: Annual sales of antibacterial medicines for systemic use
(J01 based on ATC classification) were gathered from Ministry of Health and were
crosschecked by sample data from suppliers and distributors. The cost of medi-
cines according to DDD (Defined Daily Dose) was calculated in Iranian Rials (IRR)
and Dollars (USD) based on average exchange rate in each year. These costs were
compared to GDP per capita, the salary of lowest paid worker in MOH and standard
cost of household basketwhich officially announced by the central bank. RESULTS:
Tetracyclines (J01A) and Sulfonamides (J01E) were the cheapest antibacterial treat-
mentswhile Amphenicoles (J01B) and unclassified antibacterials such as Vancomi-
cine (J01X) were themost expensive treatment for bacterial infections. The average
cost of antibacterial medicines was 0.3USD/DDD which equals to 3.5% of daily
income of the lowest paid worker and 2.5% of daily GDP/capita. The trend of com-
parative costs did not show any significant changes during the period.
CONCLUSIONS: A moderate growth was observed in daily cost of antibacterial
therapy while IRR is the unit of measurement. But when the currency changes to
USD or when costs compare to daily income of the lowest paid worker or to GDP/
Capita, No growth was observed. Apart from changes of the trends, the cost of
antibacterial therapy was too cheap to put a catastrophic expense on the health
system.
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Establishing essential medicine policy (EMP) is one of 5 health system reform pil-
lars in China in 2009. After three-year implementation, the strengthens and weak-
nesses of EMP need to be monitoring and evaluation. OBJECTIVES: The paper re-
views the process of listing, pricing, purchasing, utilization and reimbursement of
essentialmedicines and discusses the achievements and issues of EMP.METHODS:
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